SCHEMBL8930585

SCHEMBL8930585

CS(=O)(=O)[C@@]1(n2ccc(=O)[nH]c2=O)O[C@H](CO)[C@@H](O)[C@H]1O

nearest known ligand 0.45

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
SLC28A1 O00337 1/20 0.45
SLC28A2 O43868 1/20 0.45
SLC29A1 Q99808 1/20 0.45
SLC28A3 Q9HAS3 1/20 0.45
P2RY14 Q15391 6/20 0.38
P2RY2 P41231 5/20 0.34
P2RY6 Q15077 8/20 0.34
P2RY4 P51582 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29049894 0.87 SLC28A1 (0.44) SLC28A1SLC28A2SLC29A1SLC28A3P2RY14
SCHEMBL6002015 0.81 SLC28A1 (0.50) SLC28A1SLC28A2SLC29A1SLC28A3P2RY14
SCHEMBL12658269 0.81 SLC28A1 (0.50) SLC28A1SLC28A2SLC29A1SLC28A3P2RY14
SCHEMBL42133 0.81 SLC28A1 (0.50) SLC28A1SLC28A2SLC29A1SLC28A3P2RY14
Ammonia Solution, Strong SCHEMBL28145131 0.80 SLC28A1 (0.49) SLC28A1SLC28A2SLC29A1SLC28A3P2RY14
Hydrogen Sulfide SCHEMBL28043850 0.80 SLC28A1 (0.49) SLC28A1SLC28A2SLC29A1SLC28A3P2RY14
SCHEMBL27355175 0.80 TK1 (0.40)
SCHEMBL30514301 0.80 SLC28A1 (0.51) SLC28A1SLC28A2SLC29A1SLC28A3P2RY14
SCHEMBL425154 0.79 SLC28A1 (0.50) SLC28A1SLC28A2SLC29A1SLC28A3P2RY14
SCHEMBL19666777 0.79 SLC28A1 (0.50) SLC28A1SLC28A2SLC29A1SLC28A3P2RY14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0549615-A4 SUGAR MODIFIED OLIGONUCLEOTIDES THAT DETECT AND MODULATE GENE EXPRESSION ISIS PHARMACEUTICALS INC (US) 1997-08-27 EP disclosed
EP-0549615-A1 SUGAR MODIFIED OLIGONUCLEOTIDES THAT DETECT AND MODULATE GENE EXPRESSION ISIS PHARMACEUTICALS, INC. (US) 1993-07-07 EP disclosed
WO-1992003568-A1 SUGAR MODIFIED OLIGONUCLEOTIDES THAT DETECT AND MODULATE GENE EXPRESSION ISIS PHARMACEUTICALS, INC. (US) 1992-03-05 WO disclosed